Healthcare Business News

WEST PALM BEACH, FL–(Marketwire – July 22, 2010) – HearUSA, Inc. (NYSE Amex: EAR), a leader among the nation’s hearing care providers, will hold a conference call on Tuesday, August 10, 2010 to discuss results for the second quarter ended June 26, 2010. Financial results will be issued in a press release after the close of the market on the same day.

HearUSA’s Chairman and CEO Stephen J. Hansbrough, President and COO Gino Chouinard, and CFO Frank Puñal will host the call starting at 4:30 p.m. Eastern time. A question and answer session will follow management’s presentation.

To participate in the call, dial the appropriate number 5-10 minutes prior to the start time, request the HearUSA conference call and provide the conference ID: 7HEARUSA.

A Web audio simulcast and replay will be available via the investor relations section of the company’s website at www.hearusa.com.

If you have any difficulty connecting with the conference call or webcast, please contact Liolios Group at 1-949-574-3860.

A telephone replay of the call will be available later that evening and will be accessible until August 17, 2010:

About HearUSA
HearUSA is the recognized leader in hearing care for the nation’s top managed care organizations through its 177 company-owned centers and network of more than 2,000 hearing care providers. HearUSA is the nation’s only hearing care provider accredited by URAC, an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation. HearUSA is also the administrator of the AARP Hearing Care program, designed to help millions of Americans aged 50+ who have untreated hearing loss. For more information about HearUSA visit www.hearusa.com, or go to www.hearingshop.com for a wide selection of hearing related products available for purchase online.

BELGRADE, SERBIA–(Marketwire – July 22, 2010) – Hard to Treat Diseases, Inc. (PINK SHEETS:HTDS) http://www.htdsmedical.com) is pleased to announce that researchers from its Slavica BioChem (www.slavicabiochem.com) division established the cooperation with world-leading market analysis company from UK.

Dr. Sanja Pekovic, Chief Project Scientist of HTDS, said, “The Datamonitor Group (http://www.datamonitor.com/) is world leader in the business intelligence sector. We expect that the multiple sclerosis and traumatic brain injury pipeline and unmet analysis needs of these two markets, prepared by Datamonitor’s healthcare and pharmaceutical analysis team, will provide us with insight into most recent findings in order to be a step ahead to our competitors. After getting permission, complete material comprising of clinical opinion, leader intelligence, best-in-class case studies, R&D pipeline, unmet need analysis, scenario-based revenue, epidemiology forecasting, a slide pack and a data pack covering seven major markets (US, France, Germany, Italy, Spain, UK, and Japan) will be available at the HTDS (http://www.htdsmedical.com) and Slavica BioChem (www.slavicabiochem.com) web sites.

About Mina Mar Group:

Mina Mar Group (MMG) is a corporate consultancy firm that specializes in small cap or OTC market business services, including public markets in Frankfurt, Germany, and the UK. We provide our clients with comprehensive advisory and consulting services regarding mergers and acquisitions, including reverse mergers of private companies into publicly traded entities, and special purpose companies (SPC) offshore. MMG also offers a full suite of related ancillary services subsequent to the successful completion of a reverse merger, including private placements, Pink Sheets Adequate Disclosure documentation, various SEC regulatory filings and a broad range of other corporate governance matters. Mina Mar Marketing Group, MMMG (www.minamargroup.net), offers publicly traded companies full array of services such as Investor Relations and maintenance investor awareness. Mina Mar Group pioneered the “Go Public Free” program, the first firm to challenge the short sellers, stock bashers and repeal of the “Communication Decency Act”. Visit www.minamargroup.com/ice to learn more.

Filings for this event are currently being reviewed and will be filed with Pink Sheets and Client Support section in due course. To be included in company’s email database for press releases, “Friday Tips” industry updates, and non-weekly activity in the company that may or may not be news released, please subscribe for opt in mailer at http://www.minamargroup.com/updates.

Safe Harbor Statement

Information in this filing may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision’s under the Private Securities Litigation Reform Act of 1995. The words or phrases “can be,” “expects,” “may affect,” “believed,” “estimate,” “project,” and similar words and phrases are intended to identify such forward-looking statements. HTDS Corporation cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases, Inc. is not a guarantee of future performance. None of the information in this filing constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases, Inc.’s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard to Treat Diseases, Inc.’s control. In addition to those discussed in Hard to Treat Diseases, Inc.’s press releases, public filings, and statements by Hard to Treat Diseases, Inc.’s management, including, but not limited to, Hard to Treat Diseases, Inc.’s estimate of the sufficiency of its existing capital resources, Hard to Treat Diseases, Inc.’s ability to raise additional capital to fund future operations, HTDS Corporation’s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Hard to Treat Diseases, Inc.’s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard to Treat Diseases, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

ALEXANDRIA, VA–(Marketwire – July 22, 2010) – Darius Gilbert, CEO of Dynamic Solutions, a strength training company, announced that his speed and performance training programs will incorporate the proprietary Movement Training Systems (MTS) Body Position evaluation and performance improvement processes.

As summer training camps and clinics kick into high gear to prepare athletes for the fall sports season, athletes of all ages are looking to increase total body strength and speed in specific sports through strength training. Dynamic Solutions is placing greater emphasis on “movement mechanics.” Movement mechanics are used to teach an athlete how to stabilize position, carry the body in motion, and correctly initiate motion. 

Through its web-based tools, MTS measures flow of muscle reaction from the foot through the entire body which dramatically improves motion, strength, athleticism and speed in young athletes. Through the MTS process, Dynamic Solutions can evaluate the strengths and weaknesses of the individual athlete and structure drills to cue changes for each athlete and increase athletic performance.

“In order to improve speed and performance, we need to measure the initial level of each athlete’s ability,” said Gilbert. “Evaluation becomes our most valuable tool in the process of performance improvement and MTS fills this need.”

“Our goal is to help each athlete be as athletic as possible,” said Vince Stephenson, founder of MTS. “Our system was designed to help athletes, coaches and trainers better understand individual body performance for efficiency.”

Dynamic Solutions and MTS agree that performance is dependent on efficient movement. The best of sport-specific skills are only as good as they can be applied. If an athlete is off-balance, out of position or slow, skills will suffer.

For more information about Dynamic Solutions’ programs, contact: visit www.kettlebellstronginva.com or call 703-209-8696.

For more information about MTS, visit the www.movementtrainingsystems.com or contact [email protected]

id=”nav_links”>

MERIDIAN, ID–(Marketwire – July 21, 2010) –  MWI Veterinary Supply, Inc. (NASDAQ: MWIV) announced today that the Company will release financial results for its fiscal year 2010 third quarter ended June 30, 2010 and update its business outlook for its fiscal year ending September 30, 2010 on Thursday, July 29, 2010. MWI will host a conference call the same day at 11:00 am eastern time to discuss these results and its business outlook.

For calls within the United States you can access the conference call by dialing (877) 638-4561 and international callers can access the conference by dialing (720) 545-0002. Participants will be required to register their name and company affiliation for the conference call. The conference call will also be carried live on the Company’s website at www.mwivet.com. Audio replay will be made available through August 12, 2010 by calling (800) 642-1687 for calls within the United States or (706) 645-9291 for international calls using the passcode 89688546 or by accessing the Company’s website.

About MWI Veterinary Supply, Inc.:
MWI Veterinary Supply, Inc. is a leading distributor of animal health products to veterinarians across the United States and United Kingdom. The products MWI sells include pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, veterinary pet food and nutritional products. The Company markets these products to veterinarians in both the companion animal and production animal markets.

NEW YORK, NY–(Marketwire – July 21, 2010) –  Allied Healthcare International Inc. (NASDAQ: AHCI) (AIM: AHI) will host a conference call and webcast to discuss the financial and operating performance for its fiscal 2010 third quarter ended June 30, 2010 on Tuesday, August 3, 2010, at 10:00 AM Eastern Time / 3:00 PM UK Time. The call will be hosted by Sandy Young, Chief Executive Officer, and Paul Weston, Chief Financial Officer. The Company will issue its earnings press release prior to the call.

Dial-In Information
Allied invites all those interested in listening to management’s discussion of the results to join the call by dialing (877) 407-8031 for domestic participants and (201) 689-8031 for international participants. Participants may also access a live webcast of the conference call through the “Investors” section of Allied Healthcare’s Website: www.alliedhealthcare.com. 

A telephone replay will be available for one week following the call by dialing (877) 660-6853 for domestic participants and (201) 612-7415 for international participants. When prompted, please enter account number 286 and conference ID number 353906. A webcast replay will also be available and archived on the Company’s website for ninety days.

ABOUT ALLIED HEALTHCARE INTERNATIONAL INC.
Allied Healthcare International Inc. is a leading provider of flexible healthcare staffing services in the United Kingdom. Allied operates a community-based network of over 110 branches with the capacity to provide carers (known as home health aides in the U.S.), nurses, and specialized medical personnel to locations covering approximately 90% of the U.K. population. Allied meets the needs of private patients, community care, nursing and care homes, and hospitals. For more news and information please visit: www.alliedhealthcare.com.

ORLANDO, FL–(Marketwire – July 19, 2010) –  WellCity, Inc. (http://www.WellCity.com), a wellness-related social network and subsidiary of WellTek, Inc. (OTCBB: WTKN), today announced it will host a national conference call on July 22, 2010 at 9:30 pm EDT to present an important message from David George, CEO of WellCity.

The Company is rallying all network marketers to listen in on why WellCity is the single most effective medium today for creating optimum health and long-term wealth.

Subject: Important Message from David George, CEO of WellCity
Date: Thursday, July 22, 2010
Time: 9:30 pm EDT
Telephone Dial In: 1-760-569-7676
Access Code: 239460#
Self Mute/Unmute: *6

Skype Dial In: Add freeconferencecallhd.7676 to your Skype contacts
Use the Skype Dial Pad to enter the Access Code: 239460# Self Mute/Unmute *6

Note: Using Skype for these calls has additional steps than a standard Skype call.
To locate the Skype keypad to enter your access code when calling the conference, select the contact first and then the green Dial button. In the same area as the Dial button, next to the volume to the right, you will see a round drop down icon. Click on the icon and select Display Keypad from the drop down menu. After the call is connected, wait for the prompt and enter your access code using the Skype keypad followed by the # key.

About WellCity Incorporated
WellCity is a social utility where health- and wellness-minded ‘residents’ can closely commune with one another; receive support, information and encouragement from their ‘neighbors’ and from a league of leading professional experts; shop for health and wellness-oriented product and services; compete in WellCity’s proprietary 90-Day Wellness Challenge; and even enjoy income opportunities by leveraging their personal network. For more information on the Company, please visit www.WellCity.com.

About WellTek Incorporated
WellTek is a global health, fitness and wellness company that provides proven solutions to help address some of the world’s most pressing and costly health and wellness challenges. The Company owns and operates WellCity, Inc., a premiere wellness-related social utility that helps ‘residents’ live longer, feel better, look younger and enjoy life more as they age. The Company’s subsidiary, MedX Limited, manufactures, markets and distributes the most advanced medical exercise equipment to the medical and fitness markets. Through its wholly owned subsidiary Pure HealthyBack, Inc., WellTek is redefining healthcare delivery by providing health plans, self-insured employer groups, and consumers with a viable non-surgical, lower cost treatment for patients who are seeking lasting relief from chronic neck and back pain. For more information on the Company, please visit www.WellTekinc.com. 

Certain statements contained in this press release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective Company’s Securities and Exchange Commission filings, that may cause actual results to materially differ from projections. Although the Company believes that its expectations are reasonable assumptions within the bounds of its knowledge of its businesses, expectations, representations and operations, there can be no assurance that actual results will not differ materially from their expectations. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include the Company’s ability to execute properly its business model, to raise additional capital to implement its continuing business model, the ability to attract and retain personnel — including highly qualified executives, management and operational personnel, ability to negotiate favorable future debt facilities and capital raises, and the inherent risk associated with a diversified business to achieve and maintain positive cash flow and net profitability. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will, in fact, occur. 

CLARKSTON, MI–(Marketwire – July 19, 2010) –  RDM Associates, a specialized accounting and business consulting firm based in Clarkston, Mich., has announced the appointment of Cynthia Sikina to the newly-created position of CEO, according to company president and founder Rick Miller.

“We’re thrilled to have Cindy joining RDM Associates,” said Miller. “She brings well-rounded senior management talent and experience which are an exceptional fit with our goals and strategies. We’ve had the opportunity to work with Cindy in the past and we’ve been very impressed with her executive skills. Our accounting services model is non-traditional and technology intensive — concepts she relates to. I know that she will be a great asset to our firm as we work together to manage the next phase of our growth and expand our range of client services.”

Ms. Sikina’s responsibilities encompass the overall management of the firm’s business, including overseeing strategic planning, client services, new business and staff development. 

Since 2007, Ms. Sikina served as senior vice president and chief financial officer for Detroit’s Karmanos Cancer Institute & Center, where she was responsible for all aspects of fiscal management. Previous management positions have included COO/CFO for Wayne State University’s Physician Group from 2001-2007; director of financial services for the University of Michigan Medical School and other positions since 1992; and prior various financial planning and accounting roles for industrial companies beginning in 1981.

Prior to her role as CFO at KCI, Ms. Sikina served as a member of the KCI Board of Directors and its Finance and Executive committees for 6 years. She has also served as a member of the Karmanos-Crittenton Health Services Board of Directors.

She received an MBA with distinction from the University of Michigan Graduate School Of Business Administration in 1989 and is a member of the Beta Gamma Sigma Honor Society for high scholastic achievement. She earned a BBA degree with distinction from U of M in 1981 and received the CPA Certificate of Examination.

Ms. Sikina lives with her husband, Mark Sikina, in Novi.

LONG ISLAND, NY–(Marketwire – July 19, 2010) –  SciMeDent Health, Corp. f/k/a Trend Exploration, Inc. (“TRDX” or the “Company”) (PINKSHEETS: TRDX) today announces to its shareholders that its negotiations are progressing well towards a definitive agreement with Genesis Biopharma, Inc. (“Genesis”) to acquire an exclusive worldwide sublicense for a new compound in development for the treatment of Painful Diabetic Neuropathy (PDN).

The Company expects the definitive agreement and subsequent closing to be finalized in a reasonably short period of time.

Dr. Jan Stahl, CEO of TRDX, commented: “We are pleased to be nearing completion of negotiations with Genesis. Additionally, plans for funding the development of Genesis’ PDN solution are progressing. We look forward to the successful completion of these key milestones in the near future.”

About Genesis Biopharma, Inc.

Genesis Biopharma, Inc. (www.genesisbiopharma.com) is a Canadian corporation founded in 2007 to exploit the commercial potential for the therapeutic use of peptidomimetic (modified amino acid peptides) compounds. Amino acids are the building blocks of proteins, which are found in every cell of every living thing on Earth. Proteins consist of extremely long and complex amino acid chains. In contrast, a peptide is a short string of amino acids, joined by chemical bonds (also called “amide bonds”).

About SCIMEDENT f/k/a Trend Exploration, Inc. (PINKSHEETS: TRDX)

SciMeDent (www.scimedenthealth.com) is a company focused on being a leading developer and marketer of products and services for medicine, dentistry and life sciences. SciMeDent plans to achieve growth initially through mergers and acquisitions.

Cautionary Statement Regarding Forward-Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological or industry changes and uncertainties related to the development of the Company’s business model. The actual results the Company may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.

VICTORIA, BRITISH COLUMBIA–(Marketwire – July 16, 2010) – Vigil Health Solutions Inc. (TSX VENTURE:VGL)(“Vigil”) today announced that it has entered into an aggregate $200,000 loan agreement with British Columbia Discovery Fund (VCC) Inc. and GrowthPoint Capital Corp. The loan is secured by all of Vigil’s property and is due and payable on December 31, 2010. The loan is convertible at the option of the lenders into Vigil’s common shares at a rate of one common share for each $0.10 of indebtedness ($0.20 if Vigil’s proposed consolidation announced below occurs). Any common shares issued on conversion of the loan will be subject to a four month hold period from today’s date. The obligations of Vigil and the lenders under the loan agreement are conditional upon receipt of acceptance by the TSX Venture Exchange of the loan.

Vigil will seek shareholder approval at its Annual General and Special Meeting of shareholders to be held on August 24, 2010, to consolidate its common shares at a ratio of one new share for each twenty outstanding common shares. In order to be effective, the consolidation resolution must be approved by at least three-quarters of the shareholder votes cast at the meeting and be accepted by the TSX Venture Exchange. The purpose of the share consolidation is to facilitate future financings and strategic initiatives by Vigil. Vigil currently has 100,046,135 common shares outstanding. If the consolidation is approved, Vigil will have approximately 5,002,306 common shares outstanding. Vigil’s name will not be changed in connection with the proposed consolidation.

COLUMBIA, SC–(Marketwire – July 15, 2010) –  BDI Pharma, Inc. (BDI), the nation’s fastest growing national distributor of biotech therapies, announced that, in spite of the uncertainty of the nation’s current economic climate, Sales Revenues continued to rise during the first two (2) fiscal quarters of 2010. This expansion of business represented an increase of fifteen percent (15%) above that for the same period in 2009 and exceeded the company’s forecasted growth for the first six (6) months of the year. The Specialty Biopharmaceutical class of products, primarily in the clinical areas of Oncology and Infectious Disease, served as the primary driver for Sales Revenue during this period. Also notable were gains within the Protein Biotherapeutics class, specific to the Hemophilia and Hyper-Immune product lines.

In addition, BDI Pharma realized significant growth in staffing through new hires during Q2 2010. Over the past ninety (90) days, the size of the company’s Biopharmaceutical Sales Staff grew by twenty percent (20%). The company also experienced growth within the BDI Promotions Division (the company’s Advertising and Promotional Division), as well as the Corporate Customer Service Division and established a new specialty sales division during the past quarter.

“Growth, at BDI Pharma, is not just an objective, it is an expectation and, as such, it is something for which we plan and prepare,” said William A. Shirey, III, Executive VP. “The key to BDI Pharma’s growth can be found in our commitment to incorporate a relatively simple matter — the strategic allocation of corporate resources — and to merge it with something far more difficult — the actual expense of those resources in a conscientious manner. Many companies adopt the former, but ultimately bend in response to market pressure and lose their will to integrate the latter. At BDI Pharma, we apply both with equal veracity as we strive to supply substantial, quantifiable value to our customers and manufacturing trade partners, alike.”

About BDI Pharma, Inc.

Since 1995, BDI Pharma, Inc. (formerly known as Blood Diagnostics, Inc.) has built an exceptional reputation as the industry trusted source for products and service. The company has exhibited an exemplary track record providing an unparalleled level of customer service, market data and product integrity to both its customer base and trade partners. Such commitment to the product channel has earned BDI recognition as “ADR,” or Authorized Distributor of Record, for the manufacturers it represents. BDI’s specialty pharmaceutical focus is evident in its commitment to biotherapeutics, chemotherapies, vaccines and plasma protein therapies, including albumin, IVIG, coagulation factors, high-titer immune globulins, and injectables. 

BDI Pharma defines its customer-centric approach to serving the nation’s healthcare community through innovative inventory supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent need delivery. An open-access resource for reference material, educational literature, market data and online ordering, BDI Pharma’s home web page www.bdipharma.com has become an industry renowned point of reference. Proprietary programs for product consignment (www.consignadvantage.com), influenza vaccine pre-booking (www.securiflu.com), vaccine ordering (www.securivax.com) and purchasing/reward programs (www.qoreprogram.com and www.securigam.com) round out a family of solutions tailored to the needs of the healthcare community at large.

ORLANDO, FL–(Marketwire – July 15, 2010) –  WellCity, Inc. (http://www.WellCity.com), a wellness-related social network and subsidiary of WellTek, Inc. (OTCBB: WTKN), today announced a strategic partnership with XOOMA Worldwide (http://www.XoomaWorldwide.com), a global network marketing company, in which the two companies have collaborated to bring more than 200,000 new users, cutting edge wellness products, a robust infrastructure and a major distribution system into WellCity. The agreement serves as a catalyst for both companies to carry out its rapid expansion plans.

As part of the relationship, XOOMA will provide exclusive support with product distribution and logistics, one of XOOMA’s strongest assets. The two companies also agreed to work on future product development together.

“Our collaboration with WellCity is about joining our global mission of Changing the Health of a Generation with a true innovator in social networking,” said Ron Howell, President and CEO of XOOMA Worldwide. “We believe that the combination of WellCity and XOOMA’s strengths will be incredibly attractive to our distributors as well as WellCity ‘residents.'”

Randy Lubinsky, Chairman and CEO of WellTek, noted, “XOOMA provides WellCity with an immediate global platform and 200,000 new ‘residents,’ exposing us to a much larger audience. It’s a global brand that people already recognize.” Lubinsky continued, “The superiority of XOOMA products is consistent with the Gold Standard of our other brands. Partnering with XOOMA is a natural progression to our tactical expansion initiative and integrates well into WellTek’s growing portfolio of trusted health, fitness and wellness brands.”

About XOOMA Worldwide
XOOMA Worldwide is a global network marketing company distributing cutting edge health and wellness products: including vitamins and minerals, functional health beverages and weight loss and skin care products to over 60 countries around the world. XOOMA’s Scientific Advisory Board provides education and guidance on health related topics and peer-reviewed scientifically supported nutritional applications for prevention and optimal health support.

About WellCity Incorporated
WellCity is a social utility where health- and wellness-minded ‘residents’ can closely commune with one another; receive support, information and encouragement from their ‘neighbors’ and from a league of leading professional experts; shop for health and wellness-oriented product and services; compete in WellCity’s proprietary 90-Day Wellness Challenge; and even enjoy income opportunities by leveraging their personal network. For more information on the Company, please visit www.WellCity.com.

About WellTek Incorporated
WellTek is a global health, fitness and wellness company that provides proven solutions to help address some of the world’s most pressing and costly health and wellness challenges. The Company owns and operates WellCity, Inc., a premiere wellness-related social utility that helps ‘residents’ live longer, feel better, look younger and enjoy life more as they age. The Company’s subsidiary, MedX Limited, manufactures, markets and distributes the most advanced medical exercise equipment to the medical and fitness markets. Through its wholly owned subsidiary Pure HealthyBack, Inc., WellTek is redefining healthcare delivery by providing health plans, self-insured employer groups, and consumers with a viable non-surgical, lower cost treatment for patients who are seeking lasting relief from chronic neck and back pain. For more information on the Company, please visit www.WellTekinc.com. 

Certain statements contained in this press release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective Company’s Securities and Exchange Commission filings, that may cause actual results to materially differ from projections. Although the Company believes that its expectations are reasonable assumptions within the bounds of its knowledge of its businesses, expectations, representations and operations, there can be no assurance that actual results will not differ materially from their expectations. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include the Company’s ability to execute properly its business model, to raise additional capital to implement its continuing business model, the ability to attract and retain personnel — including highly qualified executives, management and operational personnel, ability to negotiate favorable future debt facilities and capital raises, and the inherent risk associated with a diversified business to achieve and maintain positive cash flow and net profitability. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will, in fact, occur. 

DUERLE, BELGIUM–(Marketwire – July 15, 2010) – Remedent, Inc. (OTCBB: REMI), an
international company specializing in research, development, and
manufacturing of oral care and cosmetic dentistry products, reported
results for the final quarter and for the year ended March 31, 2010 (in US
Dollars).

Net sales in the fourth quarter decreased 27% to $2.5 million from $3.4
million in the same year ago quarter. The decrease in sales was due to non
recurring license fees of approx $1 million received from Denmat in the
fourth quarter ended March 31, 2009.

Loss from operations in the fourth quarter was a loss of $111,138 $(0.01)
per share as opposed to a loss of $1,079,063 $(0.05) in the same year-ago
quarter, based upon 20 million weighted average basic shares outstanding.

Net loss for the year ended March 31, 2010 was $2.4 million or $(0.12) per
share, as compared with a loss of $3.0 million or $(0.15) per share for the
year ended March 31, 2009.

Cash and cash equivalents totaled $614,000 at March 31, 2010 as opposed to
$1.8 million at March 31, 2009.

Management Commentary

“Our sales strategy of shifting from our previous wholesale sales (B2B)
model via a distributor to a direct retail model (B2C) is beginning to take
shape. Included in our net loss of $111,000 for the fourth and final
quarter ended March 31, 2010, was a loss of $550,000 directly attributable
to our subsidiary Sylphar. The improved results are attributable to the
inclusion for the first time of our Asian operations into our consolidated
financial statements together with the gain realized from the sale of First
Fit. Sales at all our Spa locations, namely in Beijing, Hong Kong, Taiwan
and in Europe continue to exceed our expectations as sales continue to
climb during the first quarter of the next financial year,” said Guy De
Vresse the CEO of Remedent.

Conference Call Information

Remedent will host a conference call on July 20, 2010 at 11:00 a.m. Eastern
Standard time (8:00 a.m. Pacific time) to discuss these results and its
strategic plans for the future. A question and answer session will follow
management’s presentation. To participate in the call, dial the appropriate
number 5-10 minutes prior to the start time.

Date: Tuesday,  July 20,2010
Time 11:00 a.m. Eastern time (8:00 a.m. Pacific time).
Dial in number: 1-888-677-8749
International: 1-913-312-1482

A simultaneous web cast and replay of the call will be available through
July 31, 2010. The replay pass code is 8101477.

About Remedent

Remedent, Inc. specializes in the research, development, manufacturing and
marketing of oral care and cosmetic dentistry products. The company serves
professional dental industry with breakthrough technology for dental
veneers. These products are supported by a line of professional veneer
whitening and teeth sensitivity solutions. Headquartered in Belgium,
Remedent distributes its products to more than 35 countries worldwide. For
more information, go to www.remedent.com.

Statement under the Private Securities Litigation Reform Act of 1995

Statements in this press release that are “forward-looking statements” are
based on current expectations and assumptions that are subject to risks and
uncertainties. Such forward-looking statements involve known and unknown
risks, uncertainties and other unknown factors that could cause Remedent’s
actual operating results to be materially different from any historical
results or from any future results expressed or implied by such
forward-looking statements. In addition to statements that explicitly
describe these risks and uncertainties, readers are urged to consider
statements that contain terms such as “believes,” “belief,” “expects,”
“expect,” “intends,” “intend,” “anticipate,” “anticipates,” “plans,”
“plan,” “projects,” “project,” to be uncertain and forward-looking. Actual
results could differ materially because of factors such as Remedent’s
ability to achieve the synergies and value creation contemplated by the
proposed transaction. For further information regarding risks and
uncertainties associated with Remedent’s business, please refer to the risk
factors described in Remedent’s filings with the Securities and Exchange
Commission, including, but not limited to, its annual report on Form 10-K
and quarterly reports on Form 10-Q.

                      REMEDENT, INC. AND SUBSIDIARIES
                  CONSOLIDATED STATEMENTS OF OPERATIONS
                                (unaudited)



                           Three months ended            Year ended
                                March 31,                 March 31,
                            2010         2009         2010         2009
                        -----------  -----------  -----------  -----------
Net sales               $ 2,472,815  $ 3,390,355  $ 8,247,940  $14,639,541
Cost of sales               952,189    1,650,315    4,322,680    6,614,723
                        -----------  -----------  -----------  -----------
  Gross profit            1,520,626    1,740,040    3,925,260    8,024,818
                        -----------  -----------  -----------  -----------
Operating Expenses
Research and development     39,850       24,273      271,195      248,652
Sales and marketing         461,078      370,042    1,352,260    2,793,970
General and
 administrative           1,313,812    1,639,656    4,524,324    5,312,192
Depreciation and
 amortization               168,218      173,903      726,499      615,674
                        -----------  -----------  -----------  -----------
TOTAL OPERATING
 EXPENSES                 1,982,958    2,207,874    6,874,278    8,970,488
                        -----------  -----------  -----------  -----------
  OPERATING LOSS           (462,332)    (467,834)  (2,949,018)    (945,670)
                        -----------  -----------  -----------  -----------
NON-OPERATING (EXPENSE)
 INCOME 
Warrants issued pursuant
 to Distribution Agreement       --           --     (168,238)  (4,323,207)
Gain on disposition of OTC       --           --           --    2,830,953
IMDS provision                   --     (300,000)          --     (300,000)
Interest expense/other
 deductions                 (50,596)    (166,972)    (171,364)    (417,147)
Interest income/other
 income                      54,907        1,884      170,244      348,997
Other income                     --           --     (169,358)          --
                        -----------  -----------  -----------  -----------
TOTAL OTHER INCOME
 (EXPENSES)                   4,311     (465,088)    (168,238)  (1,860,404)
                        -----------  -----------  -----------  -----------

LOSS FROM CONTINUING
 OPERATIONS BEFORE
 INCOME TAXES              (458,021)    (932,922)  (3,118,376)  (2,806,074)
Income tax expense          (14,242)     (32,633)     (14,242)     (32,633)
                        -----------  -----------  -----------  -----------

NET LOSS FROM CONTINUING
 OPERATIONS BEFORE
 MINORITY INTEREST         (472,263)    (965,555)  (3,132,618)  (2,838,707)
NET (LOSS) INCOME
 ATTRIBUTABLE TO
 NON-CONTROLLING
 INTERESTS                 (346,683)     114,208     (782,703)     114,208
                        -----------  -----------  -----------  -----------

NET LOSS FROM CONTINUING
 OPERATIONS, ATTRIBUTABLE
 TO REMEDENT INC. COMMON
 STOCKHOLDERS           $  (111,138) $(1,079,763) $(2,349,915) $(2,952,915)
                        ===========  ===========  ===========  ===========

LOSS PER SHARE
Basic and fully diluted $     (0.01) $     (0.06) $     (0.12) $     (0.15)
                        ===========  ===========  ===========  ===========
WEIGHTED AVERAGE
 SHARES OUTSTANDING
Basic and fully
 diluted                 19,995,969   19,995,969   19,995,969   19,559,653
                        ===========  ===========  ===========  ===========

OTHER COMPREHENSIVE
 INCOME (LOSS):
Net loss attributable
 to Remedent, Inc.
 common stockholders    $  (111,138) $(1,079,763) $(2,349,915) $(2,952,915)
Foreign currency
 translation adjustment    (102,949)     (45,371)      (9,464)    (668,245)
                        -----------  -----------  -----------  -----------
Total other comprehensive
 loss                      (214,287)  (1,125,134)  (2,359,379)  (3,621,160)
Less: comprehensive
 (loss) income
 attributable to
 non-controlling
 interest                   (42,623)     (54,700)       7,130      (54,700)
                        -----------  -----------  -----------  -----------
COMPREHENSIVE LOSS
 ATTRIBUTABLE TO
 REMEDENT INC.,
 COMMON STOCKHOLDERS    $  (171,664) $(1,070,434) $(2,366,509) $(3,566,460)
                        ===========  ===========  ===========  ===========




                      REMEDENT, INC. AND SUBSIDIARIES
                        CONSOLIDATED BALANCE SHEETS


                                              March 31,2010  March 31,2009
                                              -------------  -------------
ASSETS
CURRENT ASSETS:
Cash and cash equivalents                     $     613,466  $   1,807,271
Accounts receivable, net of allowance for
 doubtful accounts of $65,845 at March 31,
 2010 and $33,966 at March 31, 2009                 806,931      3,208,120
Inventories, net                                  2,161,692      1,937,946
Prepaid expense                                     920,487      1,310,900
                                              -------------  -------------
Total current assets                              4,502,576      8,264,237
                                              -------------  -------------
PROPERTY AND EQUIPMENT, NET                       1,735,719      1,024,999
OTHER ASSETS
Long term investments and advances                  750,000        750,000
Patents, net                                        246,992        163,106
Goodwill                                            699,635             --
                                              -------------  -------------
Total assets                                  $   7,934,922  $  10,202,342
                                              =============  =============
LIABILITIES AND STOCKHOLDERS' EQUITY
 (DEFICIT)
CURRENT LIABILITIES:
Current portion, long term debt               $     215,489  $      78,798
Line of Credit                                      674,600        660,200
Accounts payable                                  1,932,684      1,398,420
Accrued liabilities                                 491,536      1,590,360
Due to related parties                              268,484             --
Income taxes payable                                     --         39,339
                                              -------------  -------------
Total current liabilities                         3,582,793      3,767,117
  Long term debt less current portion               425,882        100,542
                                              -------------  -------------
Total liabilities                                 4,008,675      3,867,659
                                              -------------  -------------

EQUITY:
Preferred Stock $0.001 par value (10,000,000
 shares authorized, none issued and
 outstanding)                                           --            --
Common stock, $0.001 par value; (50,000,000
 shares authorized, 19,995,969 shares issued
 and outstanding at March 31, 2010 and
 19,995,969 shares issued and outstanding at
 March 31, 2009)                                     19,996         19,996
Treasury stock, at cost; 723,000 and 723,000
 shares at March 31, 2010 and March 31, 2009
 respectively                                      (831,450)      (831,450)
  Additional paid-in capital                     24,742,201     24,106,055
Accumulated deficit                             (19,565,943)   (17,216,028)
Accumulated other comprehensive income (loss)
 (foreign currency translation adjustment)         (650,059)      (640,595)
Obligation to issue shares                           97,500             --
                                              -------------  -------------
Total Remedent, Inc. stockholders' equity         3,812,245      5,437,978
                                              -------------  -------------
Non-controlling interest                            114,002        896,705
                                              -------------  -------------
Total stockholders' equity                        3,926,247      6,334,683
                                              -------------  -------------
Total liabilities and equity                  $   7,934,922  $  10,202,342
                                              =============  =============

NEW YORK, NY–(Marketwire – July 15, 2010) –  Healthnostics, Inc. (PINKSHEETS: HNSS), a medical manufacturing and biotechnology analytics company, has sold an interest in MedBioWeb, Corp., in exchange for 150 million shares of its common stock, thereby reducing the actual issued and outstanding shares of Healthnostics, Inc., to 155,857,509.

As the Company refocuses its business, it is contemplating the possibility of a sale of its remaining interest in MedBioWeb Corp. MedBioWeb Corp. may more readily achieve its profit goals as an independent company and Healthnostics, through its recent acquisition, may be more able to show a substantial increase in per share earnings due to the near halving of outstanding shares.

The Company will continue to pursue acquisitions that are both compatible and synergistic.

“The Company is witnessing dramatic changes, all of which we believe bode well for our stockholders. We are focusing on profitability and earnings per share, factors that will enhance our ability to thrive and grow,” said Alan Grofe, president.

About Healthnostics
Healthnostics, Inc. is a medical and biotechnology analytics company that provides comprehensive patient clinical monitoring and risk management systems to acute care hospitals and utilizes its Internet portals to deliver medical and biotechnology resource information to industry professionals as well as to the general public. Healthnostics’ major products include: Worldwide Wipes Co., a manufacturer and distributor of medical and other wipes, MedGuardian, a patient care monitoring and risk management system for hospitals that is fully Web-based; and through the MedBioWeb subsidiary, MedBioWorld™, one of the largest professional medical and biotechnology directory resource and reference portal sites on the Internet, and FamilyMedicalNet, a companion consumer healthcare information portal.
For further information please visit Healthnostics www.healthnostics.com, and Worldwide Wipes Co. www.wipesco.com, MedBioWorld www.medbioworld.com, and FamilyMedicalNet www.familymedicalnet.com.

And visit us on Facebook at www.facebook.com/Healthnostics.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management’s current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

MARKHAM, ONTARIO–(Marketwire – July 15, 2010) – Extendicare Real Estate Investment Trust (“Extendicare REIT” or the “REIT”) (TSX:EXE.UN) today announced that it has declared a cash distribution of C$0.07 per unit of the REIT (the “REIT Units”) for the month of July 2010, which is payable to unitholders of record at the close of business on July 30, 2010, and will be paid on August 16, 2010.

Extendicare Limited Partnership (the “Partnership”) also announced that it has declared a cash distribution of C$0.07 per Class B limited partnership unit (the “Exchangeable LP Units”) for the month of July 2010, which is payable to unitholders of record at the close of business on July 30, 2010, and will be paid on August 16, 2010.

The current annualized distribution rate of the REIT and Partnership is C$0.84 per unit, payable in monthly distributions of C$0.07 per unit. In accordance with the distribution policy of both the REIT and the Partnership, unitholders of record at the close of business on the last business day of each calendar month will be paid a distribution on or about the 15^th day of the following month.

Management estimates that approximately 70% of the 2010 distributions of the REIT and Partnership will be characterized as tax-deferred returns of capital for Canadian residents. To the extent the remaining 30% of distributions of the REIT and Extendicare LP to be made in 2010 are taxed as dividends, those paid to Canadian residents are eligible dividends as per the Income Tax Act (Canada). The REIT is not required to, and does not, calculate its “earnings and profits” pursuant to the United States Internal Revenue Code of 1986, as amended, and therefore no portion of its distributions represent qualified dividend income for U.S. tax purposes.

The REIT has a Distribution Reinvestment Plan, which provides Canadian resident holders of REIT Units and Exchangeable LP Units with the opportunity to increase their respective investments at a 3% discount to the volume weighted average trading price of the REIT Units on the TSX for the five trading days immediately preceding the distribution payment date. A copy of the Plan package is available under the investors section of the REIT’s website.

About Us

Extendicare REIT is a leading North American provider of long-term and short-term senior care services through its network of owned and operated health care centers. We employ 37,700 qualified and experienced individuals dedicated to helping people live better through a commitment to quality service that includes post-acute care, rehabilitative therapies and home health care services. Our 258 senior care centers in North America have capacity for approximately 28,900 residents. Extendicare REIT is a specified investment flow-through trust (SIFT) that has been subject to the SIFT tax since January 1, 2007.

Forward-looking Statements

Information provided by Extendicare REIT from time to time, including this release, contains or may contain forward-looking statements concerning anticipated financial events, results, circumstances, economic performance or expectations with respect to the REIT and its subsidiaries, including its business operations, business strategy, and financial condition. Forward-looking statements can be identified because they generally contain the words “expect”, “intend”, “anticipate”, “believe”, “estimate”, “project”, “plan” or “objective” or other similar expressions or the negative thereof. Forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available, and the REIT assumes no obligation to update or revise any forward- looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the REIT to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on the REIT’s forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare REIT with the securities regulatory authorities, available at www.sedar.com and on the REIT’s website at www.extendicare.com.

PORT ST. LUCIE, FL–(Marketwire – July 15, 2010) –  RightSmile, Inc. (PINKSHEETS: RIGH) (www.RightSmile.com), the leader in Cosmetic Laser Teeth Whitening, continues to add more SmileShoppes across the country, while adding monthly reoccurring revenue at the same time. Furthermore, the Company will be reducing the current amount of shares outstanding by nearly 500 million shares within the coming days.

RIGH has been adding more SmileShoppes from the efforts of the independent rep groups recently signed up. Each SmileShoppe delivers monthly reoccurring revenue to the Company of approximately $500 per month, by just adding 10 new SmileShoppes per month at the end of a year the Company will have added $60,000 a month in additional revenue. The Company also has its first full time, in-house sales person, working from the corporate office in FL, and has been making good headway into the South Florida market.

The Officers of RIGH have decided to exchange their shares of Common stock for Preferred stock to ease investors’ minds that they may be selling their shares into the market. “Management is focused on building strong shareholder value and letting the shareholders know we are in it for the long haul,” stated Gene Caiazzo, President.

This reduction will reduce the Outstanding shares of the company’s Common stock to 550,000,000 from currently over 1 billion.

The Company has been working diligently on compiling and delivering all the information asked for by the audit team and looks forward to posting the audited financials on PinkSheets.

Once the financials are complete the company will hold its Annual Shareholders meeting this August in Fort Lauderdale, FL. As previously announced, all shareholders who attend the meeting can get their teeth whitened for free.

About RightSmile®:

Based in Port St. Lucie, Florida, RightSmile, Inc. engages in the distribution of branded and private label Cosmetic Laser Teeth Whitening products. Through Revodent, RIGH became a manufacturer of teeth whitening products. Revodent supplies numerous manufacturers/manu-packagers with components for teeth whitening solutions; in addition, they also supply final products designed for use in the dental, salon/retail and internet markets.

The Company believes all remarks made in the release to be accurate to the best of its knowledge.

The foregoing press announcement contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management’s expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Click here to see all recent news from this company

MIAMI, FL–(Marketwire – July 14, 2010) – Unity Management Group Inc. (PINKSHEETS: UYMG) is a Health Resource Company specializing in Physician and Hospital Practice Management, Medical Discount Plans, Business Services, Billing Software and Technologies.

UMGI is proud to announce that is has entered into a negotiation for an acquisition that will increase its revenue and assets.

Unity is in a due diligence stage of acquiring a healthcare related company. In the coming week we will be updating share holders with financials and corporate information of the target company.

UMGI management feel s that this can be a perfect fit and the company is fully funded.

The funding requirements for the acquisition have been obtained. Further information will be released in the next 7 business days.

Unity Management Group Inc. is also proud to announce that it has completed its disclosure statement, and legal opinion in respect that these are the listing documents that are necessary to obtain current status on the OTC markets. We foresee us receiving our PS status by Friday.

“We are proud to announce these extremely important current events. As previously mentioned this is a milestone for UMGI, and the company is working diligently to complete this acquisition, we will be announcing the outcome of these events within the next couple of business days. As always the company would like to thank its past present and future investors,” said Michael Oliver, Vice President.

For more information please goes to our website which can be found at www.unitymanagementgroup.com

Share structure:

100,000,000 million authorized

87,035,620 million issued and outstanding

43,439,460 million float

Unity Management Group, a health resource company, will continue to provide innovative physician practice management services that offer high value and significant return on investment for physicians’ practices and hospitals through its three subsidiary companies: United Healthcare Solutions Inc., Unity Technologies Inc., and United Business Services Inc.

The first subsidiary, Unity Business Services, is a full service management company offering solutions in practice management, billing, staffing, contracting, licensing, credentialing, and accounting. Unity Business Services also offers assistance in HIPPA compliance, marketing, and unique solutions for practice start-ups and new practices.

Unity Technologies Inc. is a complete software solutions company offering billing, electronic medical records, and electronic health records for physician’s offices and hospitals.

United Healthcare Solutions, a national company based in Nevada, is a healthcare company that will be providing medical, vision and dental discount plans, as well as PPO and HMO networks. 

The combination of these three subsidies provides unprecedented access to skilled leadership, managed care expertise, information systems, and economies of scale. Alex Berkovich, President of United Management Group, stated, “Through this merger, we are in a unique position to address the rapidly changing needs of the medical community. Business expertise is critical to the success of today’s physician offices and hospitals and we expect unpatrolled growth in the near future.”  

Certain information discussed in this press release may constitute forward-looking statements within the Private Securities Litigation Reform Act of 1995 and the federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions at the time made, it can give no assurance that its expectations will be achieved. Readers are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements are inherently subject to unpredictable and unanticipated risks, trends and uncertainties such as the Company’s inability to accurately forecast its operating results; the Company’s potential inability to achieve profitability or generate positive cash flow; the availability of financing; and other risks associated with the Company’s business. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events.

HOUSTON, TX–(Marketwire – July 14, 2010) –  Bederra Corporation (PINKSHEETS: BEDA) management has announced that it has submitted all necessary information to obtain Pink Sheets Current Information status and should obtain this status on otcmarkets.com within the next few days. This increased level of disclosure is intended to enhance shareholder transparency.

According to otcmarkets.com, “Companies that follow the International Reporting Standard or the Alternative Reporting Standard by making filings publicly available through the OTC Disclosure & News Service pursuant to Pink OTC Markets Guidelines for Providing Adequate Current Information are designated as Pink Sheets Current Information.” In its May 2010 OTC Market Snapshot, OTC Markets revealed that of 9,402 OTC companies, 1,237 were Pink Sheets Current Issuers. In May, trading in Pink Sheets Current Issuers accounted for more than 53% of the total trading dollar volume of OTC companies.

The company also announced that it has changed its Transfer Agent and has employed Transfer Online to streamline its securities management.

Management continues to seek additional acquisitions and diversification in an effort to bring long-term value to shareholders.

In the coming weeks the company will announce several actions that management believes will increase the long-term success of the company.

About Bederra Corp.
http://www.bederra.com
Bederra Corporation provides multiple modality diagnostic medical services to the greater Houston area and the world famous Texas Medical Center. The Company’s business strategy is to continue to expand its current operations and seek out additional acquisitions that will complement its core offerings.

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company’s expectations with regard to the future impact on the company’s results from new products and services in development, including any planned acquisitions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements might not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company’s plans or expectations.

DUBLIN, IRELAND–(Marketwire – July 14, 2010) –   Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter of 2010 on Thursday, July 29, 2010. The Company has scheduled a conference call for that same day, Thursday, July 29, 2010 at 11:00am EDT (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

A simultaneous webcast of the call can be accessed at: http://www.videonewswire.com/event.asp?id=70724

A replay of the call can be accessed until August 3, 2010 by dialing:

The webcast of the call will be available for 30 days at: http://www.videonewswire.com/event.asp?id=70724

About Trinity Biotech plc
Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and blood coagulation disorders, and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information please see the company’s website: http://www.trinitybiotech.com. 

Forward-looking statements in this release are made pursuant to the “safe harbor” provision of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties including, but not limited to, the results of research and development efforts, the effect of regulation by the United States Food and Drug Administration and other agencies, the impact of competitive products, product development commercialisation and technological difficulties, and other risks detailed in the Company’s periodic reports filed with the Securities and Exchange Commission.

ST. PAUL, MN–(Marketwire – July 14, 2010) –  HealthEast Care System is pleased to announce that Ann Schrader, Chief Operating Officer, has received two awards in the past two months for her significant contributions to Minnesota healthcare.

Schrader was named a 2010 Health Care Hero in Administrative Excellence by Twin Cities Business magazine and Medica. She was deemed one of eight of Minnesota’s outstanding contributors to the quality of health care in the state, selected from dozens of nominees for her time, focus, compassion, commitment, efforts, and imagination in delivering significant improvements in health care. Her drive to create a patient-centered experience, gold standard employee engagement, exceptional clinical outcomes, and dependable financial performance led to this honor.

Schrader, whose roots are as an RN caring for patients at the bedside, has spent the last 30 years as a senior leader at HealthEast. In 1986, she was instrumental in the merger of several St. Paul hospitals to create HealthEast Care System, the first successful unification of hospitals representing three Christian faiths in America. Schrader became HealthEast’s Chief Operating Officer in 1994. 

As operations leader, she was part of a team that brought about many firsts for HealthEast including:

• St. Joseph’s, St. John’s and Woodwinds were the first hospitals in Minnesota to perform surgeries live on the Internet.
• Bethesda Hospital became one of only two long-term acute care hospitals in the state.
• HealthEast launched an online prenatal education program, the first of its kind in the United States.
• HealthEast implemented a care navigation strategy that was the first of its kind in the Twin Cities.
• Woodwinds Health Campus officially opened in Woodbury; it was the first hospital of its kind to offer a unique environment blending integrative medicine, technology, customer service, and a healing nature for patients and their families.

Tim Hanson, HealthEast Care System Chief Executive Officer, credits Schrader for being an essential driver of best practices at all levels of the organization. “Her sense of integrity, honesty, innovation, and accountability have been at the foundation of HealthEast’s success,” said Hanson. “Her vision and strategic planning acumen have helped us respond effectively to a constantly changing industry.”

Schrader has also been selected by the Women’s Healthcare Leadership Trust to receive its Jean Harris Award. The Trust is a 30-year-old organization whose primary purpose is to support, educate, and promote women leaders in healthcare. Established in 2001, this award reflects the vision, integrity, and public leadership of Jean Harris, a physician and former mayor of Eden Prairie, who was known for making a difference in the health care of our communities.

Over the years, Schrader has given her time and talent as a board member to many organizations reflecting a broad spectrum of interests (ranging from business leadership to social services). In addition, she has served as a coach and mentor for many aspiring leaders at HealthEast as well as MHA and MBA students from the University of Minnesota, University of St. Thomas, St. Catherine University, and Mentiumm 100.

These awards celebrate Schrader’s innovative service and program contributions to HealthEast as well as her lifetime commitment to helping young healthcare professionals grow and develop their talents and competencies.

HealthEast Care System is a community-focused, non-profit health care organization that provides innovative technology, compassionate care and a full spectrum of family health services. HealthEast includes Bethesda Hospital, St. John’s Hospital, St. Joseph’s Hospital, and Woodwinds Health Campus as well as outpatient services, clinics, home care, and medical transportation services. Practicing financial responsibility, HealthEast is the largest, locally-owned health care organization in the Twin Cities’ East Metro with 7,300 employees, 1,200 volunteers and 1,400 physicians on staff.

BENSALEM, PA–(Marketwire – July 13, 2010) – Healthcare Services Group, Inc. (NASDAQ: HCSG)
reported that revenues for the three months ended June 30, 2010 increased
13% to $192,954,000 compared to $170,896,000 for the same 2009 period. Net
income for the three months ended June 30, 2010 increased 12% to $8,721,000
or $.20 per basic and per diluted common share, compared to the 2009 second
quarter net income of $7,815,000 or $.18 per basic and per diluted common
share.

Revenues for the six months ended June 30, 2010 increased 14% to
$376,755,000 compared to $331,305,000 for the same 2009 period. Net income
for the six months ended June 30, 2010 increased 4% to $16,149,000 or $.37
per basic and $.36 per diluted common share compared to the 2009 six month
period net income of $15,551,000 or $.36 per basic and $.35 per diluted
common share.

The Board of Directors has declared a second quarter 2010 regular quarterly
cash dividend of $.23 per common share, payable on August 6, 2010 to
shareholders of record at the close of business July 23, 2010. This
represents a 5% increase over the dividend declared for the 2010 first
quarter and a 21% increase over the 2009 same period payment. It is the
29th consecutive regular quarterly cash dividend payment, as well as the
28th consecutive increase since our initiation of regular quarterly cash
dividend payments in 2003.

The Company will host a conference call on July 14, 2010 at 8:30 AM Eastern
Time to discuss its results for the three and six month periods ended June
30, 2010. The call in numbers are 800-401-3551 and 913-312-0688 (passcode #
2084962).

Cautionary Statement Regarding Forward-Looking Statements

This release and any schedules incorporated by reference into this report
contain forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934 (the “Exchange Act”), as amended, are not historical
facts but rather based on current expectations, estimates and projections
about our business and industry, our beliefs and assumptions. Words such as
“believes,” “anticipates,” “plans,” “expects,” “will,” “goal,” and similar
expressions are intended to identify forward-looking statements. The
inclusion of forward-looking statements should not be regarded as a
representation by us that any of our plans will be achieved. We undertake
no obligation to publicly update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise. Such
forward-looking information is also subject to various risks and
uncertainties. Such risks and uncertainties include, but are not limited
to, risks arising from our providing services exclusively to the health
care industry, primarily providers of long-term care; credit and collection
risks associated with this industry; one client accounting for
approximately 11% of revenues in the six month period ended June 30, 2010;
risks associated with our acquisition of Contract Environmental Services,
Inc. including integration risks and costs, or such business not achieving
expected financial results or synergies or failure to otherwise perform as
expected; our claims experience related to workers’ compensation and
general liability insurance; the effects of changes in, or interpretations
of laws and regulations governing the industry, our workforce and services
provided, including state and local regulations pertaining to the
taxability of our services; and the risk factors described in our Form 10-K
filed with the Securities and Exchange Commission for the year ended
December 31, 2009 in Part I thereof under “Government Regulation of
Clients,” “Competition” and “Service Agreements/Collections,” and under
Item IA “Risk Factors.” Many of our clients’ revenues are highly contingent
on Medicare and Medicaid reimbursement funding rates, which Congress has
affected through the enactment of a number of major laws during the past
decade, most recently the March 2010 enactment of the Patient Protection
and Affordable Care Act and the Health Care and Education Reconciliation
Act of 2010. Currently, the U.S. Congress is considering changes or
revising legislation to reform health care in the United States which,
among other initiatives, may impose cost containment measures impacting our
clients. These laws and proposed laws have significantly altered, or
threatened to alter, overall government reimbursement funding rates and
mechanisms. The overall effect of these laws and trends in the long-term
care industry have affected and could adversely affect the liquidity of our
clients, resulting in their inability to make payments to us on agreed upon
payment terms. These factors, in addition to delays in payments from
clients, have resulted in, and could continue to result in, significant
additional bad debts in the near future. Additionally, our operating
results would be adversely affected if unexpected increases in the costs
of labor and labor related costs, materials, supplies and equipment used in
performing services could not be passed on to our clients.

In addition, we believe that to improve our financial performance we must
continue to obtain service agreements with new clients, provide new
services to existing clients, achieve modest price increases on current
service agreements with existing clients and maintain internal cost
reduction strategies at our various operational levels. Furthermore, we
believe that our ability to sustain the internal development of managerial
personnel is an important factor impacting future operating results and
successfully executing projected growth strategies.

Healthcare Services Group, Inc. is the largest national provider of
professional housekeeping, laundry and dietary services to long-term care
and related facilities.

                     HEALTHCARE SERVICES GROUP, INC.
               CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                               (Unaudited)

                                               For the Three Months Ended
                                                        June 30,
                                                  2010           2009
                                              -------------  --------------
Revenues                                      $ 192,954,000  $  170,896,000
Operating costs and expenses:
   Cost of services provided                    165,240,000     145,830,000
   Selling, general and administrative           13,150,000      13,516,000
                                              -------------  --------------
Income from operations                           14,564,000      11,550,000
Other income (loss):
    Investment and interest income (loss)          (383,000)      1,157,000
                                              -------------  --------------
Income before income taxes                       14,181,000      12,707,000
Income taxes                                      5,460,000       4,892,000
                                              -------------  --------------
Net income                                    $   8,721,000  $    7,815,000
                                              =============  ==============

Basic earnings per common share               $         .20  $          .18
                                              =============  ==============

Diluted earnings per common share             $         .20  $          .18
                                              =============  ==============

Cash dividends per common share               $         .22  $          .18
                                              =============  ==============
Basic weighted average number of common shares
 outstanding                                     43,965,000      43,537,000
                                              =============  ==============

Diluted weighted average number of common
 shares outstanding                              44,652,000      44,262,000
                                              =============  ==============




                     HEALTHCARE SERVICES GROUP, INC.
               CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                               (Unaudited)

                                                 For the Six Months Ended
                                                         June 30,
                                                    2010          2009
                                                ------------- -------------
Revenues                                        $ 376,755,000 $ 331,305,000
Operating costs and expenses:
   Cost of services provided                      323,812,000   283,722,000
   Selling, general and administrative             27,051,000    24,392,000
                                                ------------- -------------
Income from operations                             25,892,000    23,191,000
Other income:
    Investment and interest income                    366,000     2,094,000
                                                ------------- -------------
Income before income taxes                         26,258,000    25,285,000
Income taxes                                       10,109,000     9,734,000
                                                ------------- -------------
Net income                                      $  16,149,000 $  15,551,000
                                                ============= =============

Basic earnings per common share                 $         .37 $         .36
                                                ============= =============

Diluted earnings per common share               $         .36 $         .35
                                                ============= =============

Cash dividends per common share                 $         .43 $         .35
                                                ============= =============
Basic weighted average number of common shares
 outstanding                                       43,932,000    43,497,000
                                                ============= =============

Diluted weighted average number of common shares
 outstanding                                       44,655,000    44,168,000
                                                ============= =============




                      HEALTHCARE SERVICES GROUP, INC.

                  CONDENSED CONSOLIDATED BALANCE SHEETS
                                (Unaudited)

                                                               December 31,
                                                June 30, 2010      2009
                                                ------------- -------------
Cash and cash equivalents                       $  34,968,000 $  31,301,000
Marketable securities, net                         44,099,000    52,648,000
Accounts receivable, net                          107,253,000   104,356,000
Other current assets                               23,715,000    23,865,000
                                                ------------- -------------
  Total current assets                            210,035,000   212,170,000

Property and equipment, net                         4,931,000     4,391,000
Notes receivable- long term, net                    6,165,000     4,623,000
Goodwill , net                                     16,955,000    17,087,000
Other Intangible Assets, net                        8,198,000     8,862,000
Deferred compensation funding                      11,238,000    10,783,000
Other assets                                        9,032,000     7,976,000
                                                ------------- -------------

Total Assets                                    $ 266,554,000 $ 265,892,000
                                                ============= =============


Accrued insurance claims- current               $   5,305,000 $   4,844,000
Other current liabilities                          27,237,000    29,873,000
                                                ------------- -------------
  Total current liabilities                        32,542,000    34,717,000

Accrued insurance claims- long term                12,377,000    11,302,000
Deferred compensation liability                    11,479,000    11,099,000
Stockholders' equity                              210,156,000   208,774,000
                                                ------------- -------------

Total Liabilities and Stockholders' Equity      $ 266,554,000 $ 265,892,000
                                                ============= =============

MUNDELEIN, IL–(Marketwire – July 13, 2010) – Medline Industries, Inc., the nation’s largest privately held manufacturer and distributor of healthcare supplies, today announced the winners of its inaugural 2009 Preferred Vendor Recognition Awards. Selected by a panel of executives from Medline’s Preferred HealthCare Division, the Preferred Vendor Awards were given to four Medline partners who not only demonstrated outstanding performance in sales and operations but also have collaborated as a true partner in Medline’s initiatives and in achieving mutual goals.

The following companies were honored at Medline’s 2010 National Meeting and Sales Conference in Montgomery, TX:

• Rookie Vendor of the Year: SunTech Medical (Morrisville, NC) was recognized for their support and sales growth of the SunTech 247 vital signs device since Medline launched the product in May 2009. 
• Vendor of the Year: Abbott Diabetes Care (Alameda, CA) was honored as the Vendor of the year who demonstrated a strong commitment to sales and marketing, as well as operational and supply chain excellence.
• Sales Merit Award: Abbott Nutritional (Columbus, OH), and Caltech Industries (Midland, MI) were both recognized for showing outstanding sales growth over the prior year while maintaining key economic initiatives.

“Our partnership with vendors is an essential element of our success with our customers,” said Maroun Abouzeid, president of Preferred HealthCare. “We thank all our partners for their contributions and congratulate our award-winning partners for their ongoing leadership.”

About Medline Industries, Inc.
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill, Medline has more than 800 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

Medline has a growing network of 34 distribution centers around the country, as well as an expanding, dedicated transportation fleet with over 180 vehicles in a variety of sizes to fit customers’ specific delivery needs. The fleet is equipped with the latest navigation devices for enhanced order tracking and communication. 

NEW YORK, NY–(Marketwire – July 13, 2010) –  Healthnostics, Inc. (PINKSHEETS: HNSS), a medical and biotechnology analytics company, has completed its acquisition of Worldwide Wipes Co., “a U.S. manufacturer and distributor of wipes for medical, veterinary, disinfecting, and a variety of other uses, and the company’s market ranges from cartons for individuals to truckloads for corporations. The Company places a priority on price, quality, and convenience, providing prompt, free shipping.”

Terms of the acquisition include net profit benchmarks of $300,000 to $600,000 in the first year and $600,000 to $900,000 in the second year.

“We are pleased to announce the completion of the most important event in our Company’s history. The Worldwide Wipes price points are exceptionally competitive, and its customer base is nationwide. Following several years of base-building, this acquisition represents such a quantum leap for Healthnostics that we are contemplating a name and stock symbol change that reflects the diversified nature and direction of the Company,” said President Alan Grofe.

About Healthnostics

Healthnostics, Inc. is a medical and biotechnology analytics company that provides comprehensive patient clinical monitoring and risk management systems to acute care hospitals and utilizes its Internet portals to deliver medical and biotechnology resource information to industry professionals as well as to the general public. Healthnostics’ major products include: Worldwide Wipes Co., a manufacturer and distributor of medical and other wipes, MedGuardian, a patient care monitoring and risk management system for hospitals that is fully Web-based; and through the MedBioWeb subsidiary, MedBioWorld™, one of the largest professional medical and biotechnology directory resource and reference portal sites on the Internet, and FamilyMedicalNet, a companion consumer healthcare information portal.

For further information please visit Healthnostics www.healthnostics.com, and Worldwide Wipes Co. www.wipesco.com, MedBioWorld www.medbioworld.com, and FamilyMedicalNet www.familymedicalnet.com.

And visit us on Facebook at www.facebook.com/Healthnostics.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management’s current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

MILWAUKEE, WI–(Marketwire – July 13, 2010) –  CPI has released a new company logo and website. The new crisisprevention.com consolidates all CPI websites, including preparetraining.com, dementiacarespecialists.com, and iancici.org, into a single enhanced and redesigned site.

Based on customer and Certified Instructor feedback, crisisprevention.com is completely revamped to include more intuitive navigation, improved account management, and an enhanced online shopping experience. It also includes a new documentation feature, which allows Certified Instructors to submit training documentation online.

The company logo has been redesigned to reflect the CPI mission and values. The logo shows people reaching out to each other with their hands, symbolizing the integral relationship between CPI and its Certified Instructors in their mission to educate, empower, and enrich the lives of others. Individual logos for each CPI specialized offering — Nonviolent Crisis Intervention^® training, Prepare Training^® program, and Dementia Care Specialists — have also been updated with a fresh, coordinated look.

According to Tony Jace, CPI chief executive officer, the new logos and website mirror the company’s commitments to expand the message of care and well-being.

“We value our commitment to increase the effectiveness of our Certified Instructors as they manage their day-to-day interactions and responsibilities. Through our new look and improved tools, we continue to provide individuals and organizations the resources they need to create safer, enriched environments,” he said.

CPI, headquartered in Milwaukee, WI, is the world’s leading training organization specializing in the safe management of disruptive and assaultive behavior. CPI’s cornerstone Nonviolent Crisis Intervention^® training and Prepare Training® programs focus on workplace violence prevention and offer effective strategies for managing anxious, hostile, or violent behavior. Through Dementia Care Specialists, CPI also offers dementia care training to improve function, safety, and quality of life. Since 1980, more than 6 million professionals have participated in CPI training, and thousands of organizations worldwide have successfully implemented CPI’s unique behavior management techniques.

TAMARAC, FL–(Marketwire – July 13, 2010) –  AcuMedSpa Holdings, Inc. (PINKSHEETS: AMSZ), a provider of Medical Aesthetic, Spa and Acupuncture services, announced it has entered into talks to make two separate acquisitions. One of the companies is domestic and the other international.

The domestic acquisition has a substantial nationwide footprint which when completed will open up several new markets for AcuMedSpa. The international acquisition is progressing well but is slightly behind the domestic one in terms of expected timeframe for finalization. When completed, it will provide AcuMedSpa with a global presence in the spa industry.

The company is also making headway with its project to open AcuMedSpa in Poland. Completion will take a little longer due to some of the legal aspects and complexities involved in dealing with the E.U.

The previous sale of the company’s “Spa within a Practice” subsidiary in the month of May, has cleared nearly half a million dollars in debt off the books and will allow AcuMedSpa to realize positive earnings in 2010. When originally stating its revenue and earnings expectations for the current year, the company took into consideration its pending acquisitions, incorporated with its current business activities. Upon completion of these two key acquisitions the company expects to meet and exceed its previously stated 2010 projections.

“Over the past few months we have been working very hard to successfully improve current operations while reducing our liabilities,” stated AcuMedSpa Holdings President Gregory Antoine. “Our objective all along has been to expand our business two ways. First through the successful acquisition of spa and aesthetic practices, and second by opening new facilities in key markets.” Mr. Antoine further commented, “Our progress so far this year together with these acquisitions nearing completion puts us on pace to exceed our $2,000,000 net income goal for 2010.”

The company also announced that its wholesale health and beauty division, Consumer Care of America LLC, is on pace to exceed expectations. The focus of this division is high volume sales. More detailed information on Consumer Care of America will be provided in a future update.

Please follow our progress on twitter: http://twitter.com/acumedinc

For additional info please visit our website: http://www.acumedspa.com/

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements as a result of various factors, and other risks. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and AcuMedSpa Holdings, Inc. takes no obligation to update such statements.

NEW ORLEANS, LA–(Marketwire – July 12, 2010) –  Hand washing and frequent wiping of surfaces like counters and handrails are necessary elements in institutional infection-control protocols. Effective as these techniques are, however, they are labor intensive, not automated, and do nothing to counter airborne bacteria — one of the primary mechanisms for the spread of disease. With the introduction of Prolitec, Inc.’s aria™ air-sanitizing agent, assisted-living facilities, hospitals, medical offices, and other enclosed spaces finally have a means of addressing this critical gap in infection control.

Prolitec’s Aerobiology and Infection Control division unveiled the new aria™ system today at the annual conference of the Washington, D.C.-based Association for Professionals in Infection Control and Epidemiology, in New Orleans.

The aria™ air-sanitizing system, which won EPA registration in November 2009, uses newly patented Prolitec technology to generate an invisible “dry” vapor of a safe and effective air sanitizing agent. The vapor can be distributed within a space directly from a small wall-mounted appliance or indirectly through an air handler. The result is a uniformly distributed vapor compliant with OSHA air-contaminant restrictions for workplace inhalation — one that is non-damaging to materials and electronics, yet significantly decreases the numbers of viable airborne bacteria under relatively wide conditions of relative humidity and temperature.

“Bacteria and other microorganisms are frequently introduced into the air by actions such as sneezing and coughing. Once microorganisms are airborne they can be inhaled or can settle and contaminate surfaces,” noted Dr. Craig A. Kelly, a veteran Johns Hopkins University scientist and chief of Prolitec’s Aerobiology and Infection-Control unit. “The function of the aria™ system is to reduce the concentration of airborne bacteria in a continuous and automated manner, thereby reducing the likelihood of inhalation or surface-settling of viable microorganisms.”

“An important feature of aria™ is that it is fully automated and works 24 hours a day, seven days a week without any human intervention,” noted Richard Weening, CEO of Milwaukee-based Prolitec. “The aria™ system can safely and effectively reduce background levels of airborne bacteria to establish the foundation of a successful infection-control protocol. It is the one part of the program that will always be 100% compliant.”

Dr. Kelly added: “Amid heightened awareness of disease transmission by airborne microorganisms, aria™ provides a critical tool for the infection-control professional to address airborne bacteria in a way that was not previously available. That can translate into a greater sense of safety and well-being for patients, residents, caregivers and visitors alike.”

About Prolitec
Prolitec (www.prolitec.com) develops and deploys air-treatment and air care technologies, including odor control, ambient scenting, aromatherapy and the use of scent as a medium of communication. Clients include assisted-living facilities, hotels, casinos, retailers and other commercial organizations in the United States and around the world. Prolitec’s Aerobiology and Infection Control Unit is developing interior air and surface systems to inhibit disease transmission.

NOTE TO EDITORS: Photos are available from Parness & Associates